SWX:MOZN
SWX:MOZNSpecialty Retail

European Stocks Trading Below Estimated Value In October 2025

As European markets experience a pullback from recent record highs, driven by political turmoil in France and renewed global trade tensions, investors are keenly observing the region for potential opportunities. In this environment of uncertainty, identifying undervalued stocks becomes crucial as these may offer attractive entry points for those looking to capitalize on discrepancies between market price and intrinsic value.
SWX:SGKN
SWX:SGKNBanks

Has St. Galler Kantonalbank’s 24.8% Climb in 2025 Left More Room to Grow?

Thinking about what to do with St. Galler Kantonalbank stock right now? You're not alone. Whether you've been impressed by its recent climb or are just weighing your options, there’s a lot happening beneath the surface. Over the last year, SGKB’s stock price has jumped a remarkable 24.8%, and it’s up 55.5% across five years. Even just this year, shares have gained 13.6%, showing real momentum despite a minor dip of 1.2% last week. Much of that long-term strength stems from steady banking...
SWX:NOVN
SWX:NOVNPharmaceuticals

Assessing Novartis (SWX:NOVN) Valuation After a Steady 2024 Climb

Novartis (SWX:NOVN) shares have moved slightly over the past week, piquing investor interest in what has been a steady climb this year. The company’s year-to-date return now sits at 17%, reflecting solid performance in 2024. See our latest analysis for Novartis. Novartis’s steady climb has been supported by consistent demand for its key therapies and a handful of smaller pipeline updates, with momentum clearly building. While the 2024 share price return stands at 16.87%, longer-term investors...
SWX:UBSG
SWX:UBSGCapital Markets

Evaluating UBS Shares After Stablecoin News and Recent Price Pullback in 2025

If you are wondering whether UBS Group stock deserves a spot in your portfolio, you are definitely not alone. With the banking sector always in the spotlight and macro headlines regularly shaking up sentiment, it is no surprise investors are trying to figure out what to do next. Despite some recent choppy waters, UBS shares have put up impressive gains over the long term, up 11.7% year-to-date and a staggering 232.6% over the last five years. But what about the short-term jitters? Over the...
SWX:HOLN
SWX:HOLNBasic Materials

European Dividend Stocks To Consider In October 2025

As European markets face a downturn with the STOXX Europe 600 Index retreating from record highs amid political turmoil and international trade tensions, investors are increasingly turning their attention to dividend stocks as a potential source of stability and income. In such volatile times, stocks that consistently provide dividends can offer a measure of resilience and appeal, particularly for those looking to navigate the current economic uncertainties while still seeking returns.
SWX:GIVN
SWX:GIVNChemicals

How J.P. Morgan's Downgrade and Fragrance Market Headwinds Have Changed Givaudan's (SWX:GIVN) Investment Story

J.P. Morgan recently downgraded Givaudan, expressing concerns about a projected slowdown in the fine fragrance market and anticipating weaker earnings growth for the company in 2026. The downgrade highlights ongoing uncertainty in consumer demand for prestige fragrances, which could place additional pressure on Givaudan's top-line performance despite its diversified business portfolio. Let's explore how J.P. Morgan's downgrade and fine fragrance market headwinds may challenge certain...
SWX:YPSN
SWX:YPSNMedical Equipment

Ypsomed Holding (SWX:YPSN) Valuation in Focus as Company Unveils First US Manufacturing Expansion

Ypsomed Holding (SWX:YPSN) has announced plans to set up its first manufacturing facility in the United States, choosing Holly Springs, North Carolina as the site. This move highlights a meaningful step in the company’s strategy for US market expansion. See our latest analysis for Ypsomed Holding. Ypsomed Holding’s announcement comes after a challenging period for the stock, with a 1-year total shareholder return of -20.15% and a recent 30-day share price return of -21.34%, reflecting...
SWX:SPSN
SWX:SPSNReal Estate

Swiss Prime Site (SWX:SPSN): Valuation Insights After Barclays Upgrade and Growth Guidance

Barclays has upgraded Swiss Prime Site (SWX:SPSN), citing the company’s guidance for 10% FFO per share growth through 2028 and continued expansion in its asset management business. The upgrade signals increased investor confidence. See our latest analysis for Swiss Prime Site. Investor sentiment around Swiss Prime Site appears to be gaining strength, with the latest analyst upgrade coming alongside a solid year-to-date share price return of 12.4%. Notably, the company’s one-year total...
SWX:CFR
SWX:CFRLuxury

Will New Leadership Shift Richemont's (SWX:CFR) Strategic Narrative?

In recent weeks, Compagnie Financière Richemont has attracted close investor attention following executive appointments at the group level and at key subsidiaries. Mixed analyst opinions on Richemont's valuation, has intensified market interest and contributed to a re-examination of the company's long-term prospects.
SWX:SCMN
SWX:SCMNTelecom

How Might Swisscom’s (SWX:SCMN) Debt Strategy Shape Its Competitive Edge in Changing Markets?

In the past week, J.P. Morgan resumed coverage of Swisscom with an 'underweight' rating, highlighting concerns about the company's competitive position in both Switzerland and Italy. An important aspect noted was Swisscom's use of a relatively high level of debt, which enhances returns but may elevate risk amid industry shifts. We’ll discuss how competitive pressures from low-cost carriers and debt usage could shape Swisscom’s investment narrative going forward. Find companies with promising...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN): Assessing Valuation After Major Robotics Division Sale and Business Restructuring

ABB (SWX:ABBN) just announced plans to divest its entire Robotics division to SoftBank Group, while also reorganizing its business by dissolving the Robotics & Discrete Automation segment. Sami Atiya, the executive overseeing Robotics, will leave the executive committee in line with this shift. See our latest analysis for ABB. ABB’s restructuring move comes after a strong stretch for the stock, with a 21% share price return over the last 90 days and a total shareholder return of nearly 139%...
SWX:BARN
SWX:BARNFood

Barry Callebaut (SWX:BARN): Evaluating Valuation Following Cocoa Price Drop and New Sales Guidance

Barry Callebaut (SWX:BARN) shares drew investor attention this week as cocoa prices hit their lowest point in nearly two years, due to better crop conditions and higher farmer payments across West Africa. See our latest analysis for Barry Callebaut. The share price has been on a roller coaster lately, with enthusiasm returning after a sharp slump. Barry Callebaut’s shares climbed 29% over the last 90 days but are still down 22% on a 1-year total shareholder return basis. Momentum has picked...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA) Valuation in Focus After Rothschild Redburn Upgrade and Growth Outlook

Rothschild Redburn’s recent upgrade has put Sika (SWX:SIKA) in the spotlight, highlighting the company’s underlying strengths and expected earnings growth. Investors are watching how Sika’s exposure to infrastructure and datacenter trends could influence future opportunities. See our latest analysis for Sika. Sika’s share price has been under pressure this year, slipping nearly 20% year-to-date and resulting in a 12-month total shareholder return of -32%. The May 2023 MBCC Group acquisition...
SWX:IDIA
SWX:IDIABiotechs

Why Idorsia (SWX:IDIA) Is Down 14.1% After Raising CHF 65.6M in Upsized Share Offering and What's Next

Earlier this week, Idorsia announced the completion of an upsized follow-on equity offering, raising CHF 65.6 million by issuing 16.4 million new and treasury shares at CHF 4 each through a direct listing. This successful capital raise, supported by strong investor demand and founding shareholder participation, aims to strengthen the balance sheet and extend funding for commercial and pipeline growth initiatives. We'll explore how the infusion of capital from the equity offering could help...
SWX:AVOL
SWX:AVOLSpecialty Retail

Avolta (SWX:AVOL): Exploring Valuation After Loyalty Partnership With King Power Expands Global Rewards Network

Avolta (SWX:AVOL) has announced a new partnership with King Power. This collaboration will enable members of both companies’ loyalty programs to enjoy reciprocal benefits and exclusive experiences at a range of global travel and retail locations. See our latest analysis for Avolta. Fresh off the announcement with King Power, Avolta’s share price has eased back 7.9% over the past month but remains up 17.2% for the year to date. Long-term shareholders have done even better, earning a 25.9%...
SWX:GIVN
SWX:GIVNChemicals

Assessing Givaudan's (SWX:GIVN) Valuation Following J.P. Morgan Downgrade on Prestige Fragrance Slowdown

J.P. Morgan’s recent downgrade of Givaudan (SWX:GIVN) has sparked discussion among investors. The move comes as the fine fragrance segment, especially prestige fragrances, faces a slowdown. This slowdown is likely to weigh on growth projections for 2026. See our latest analysis for Givaudan. While Givaudan’s participation at recent industry conferences has kept it in the spotlight, the market hasn’t been kind this year. After a tough stretch, the stock shows a year-to-date share price return...
SWX:ROG
SWX:ROGPharmaceuticals

Roche (SWX:ROG): Assessing Valuation After Recent Share Price Gains and Steady Earnings Growth

Roche Holding (SWX:ROG) has delivered steady returns for investors recently, with its share price gaining 13% year-to-date. The company's annual net income growth of 13% also points to ongoing operational momentum in its business. See our latest analysis for Roche Holding. Roche Holding’s share price has climbed 13% so far this year, reflecting a steady build in market optimism after a modest stretch. The company’s one-year total shareholder return of nearly 12% underscores continued...
SWX:CLN
SWX:CLNChemicals

Clariant (SWX:CLN) Is Down 5.0% After €2 Billion Legal Claims From BP and ExxonMobil – Has The Bull Case Changed?

Clariant recently announced it received two significant legal claims from BP Europe SE and ExxonMobil Petroleum & Chemical B.V., amounting to around €1.10 billion and €860 million respectively, following competition law infringement proceedings on the ethylene purchasing market in Germany that were sanctioned by the European Commission in 2020. This development highlights a substantial legal and financial risk for Clariant, as the company firmly rejects the claims and intends to contest the...